Insider trades

Bihua Chen, Director of BridgeBio Oncology Therapeutics BBOT, has filed 122 purchases and 24 sales on the open market. Over the past 12 months that comes to a net sale of $3.1M. The latest trade was on 06/16.

Bihua Chen

Director
First filing
23/03/22
Trades
171 trades
Buys / sales
122 / 24
12-month net buying
−$3.1M
Last trade
06/16

Trading activity

Transactions

Trade type
Open-market sale04/2804/30109,331 sh$89.50$9,785,124.5−10.3%
Open-market buyAmendment01/2601/28800,000 sh$10.00$8,000,000No record
Open-market sale25/12/1125/12/1530,029 sh$11.46$344,132.34−1.3%
Open-market sale25/12/0425/12/0860,000 sh$15.70$942,000−0.7%
MLTX
Open-market sale25/09/29–25/09/3025/10/016,499,978 sh5 trades$7.21avg.$46,868,184.1−76.5%
Open-market sale25/05/1525/05/191,813,439 sh$1.85$3,354,862.15−100.0%
Open-market sale25/05/1225/05/1424,300 sh$1.99$48,357−1.3%
Open-market buy25/02/1425/02/19187,500 sh$16.00$3,000,000+23.4%
Open-market buy24/11/0424/11/06184,331 sh$21.70$3,999,982.7+21.1%
DRUG
Open-market buy24/10/15–24/10/1624/10/17422,591 sh11 trades$7.65avg.$3,234,153.96+93.4%
Open-market buy24/09/2724/10/01450,000 sh$18.00$8,100,000+38.2%
CRBP
Open-market buy24/09/2024/09/24350,000 sh6 trades$20.01avg.$7,004,060.33+17.3%
EYPT
Open-market buy24/05/0624/05/08850,000 sh2 trades$11.86avg.$10,081,720.98+11.4%
EYPT
Open-market buy24/04/1824/04/22581,765 sh2 trades$18.03avg.$10,489,446.18+8.4%
IMRX
Open-market sale24/04/0124/04/03400,000 sh8 trades$2.90avg.$1,160,182.5−12.1%
IMRX
Open-market sale24/03/14–24/03/1524/03/18909,091 sh5 trades$3.03avg.$2,750,627.69−21.6%
CRBP
Open-market buy24/03/07–24/03/0824/03/11550,000 sh10 trades$42.41avg.$23,327,559.6+37.3%
BBOT
Open-market buy24/02/1324/02/132,400,000 sh3 trades$10.00avg.$24,000,000No record
Open-market buy24/02/0224/02/06750,000 sh$19.00$14,250,000+103.4%
CRBP
Open-market buy24/01/2624/01/30282,632 sh14 trades$32.24avg.$9,111,940.74+63.9%